We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

1 hedge funds and large institutions have $21K invested in Ventyx Biosciences in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

73.19% less ownership

Funds ownership: 73.19% → 0% (-73%)

99% less funds holding

Funds holding: 139 → 1 (-138)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 138

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $472M → $21K (-$472M)

Holders
1
Holders Change
-138
Holders Change %
-99.28%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
138
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$20.3K

Top Sellers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
-$58.6M
2
Morgan Stanley
Morgan Stanley
New York
-$38.8M
3
BlackRock
BlackRock
New York
-$28.4M
4
TCM
Tang Capital Management
California
-$25.4M
5
BBA
Baker Bros. Advisors
New York
-$21.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
– -$4.86M -538,071 Closed
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
– -$4.08M -452,310 Closed
NAMI
28
Nomura Asset Management International
Pennsylvania
– -$3.88M -430,000 Closed
SCM
29
Squadron Capital Management
Illinois
– -$3.7M -410,000 Closed
SCM
30
Sio Capital Management
New York
– -$3.5M -387,751 Closed
Charles Schwab
31
Charles Schwab
California
– -$3.46M -383,231 Closed
Adage Capital Partners
32
Adage Capital Partners
Massachusetts
– -$3.39M -375,000 Closed
Two Sigma Investments
33
Two Sigma Investments
New York
– -$3.25M -359,930 Closed
Bank of America
34
Bank of America
North Carolina
– -$2.86M -316,856 Closed
TCM
35
TCG Crossover Management
California
– -$2.86M -316,195 Closed
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
– -$2.47M -273,444 Closed
MAP
37
Moody Aldrich Partners
Massachusetts
– -$2.37M -262,938 Closed
BFM
38
Boothbay Fund Management
New York
– -$2.28M -251,994 Closed
OM
39
Opaleye Management
Massachusetts
– -$2.27M -251,932 Closed
IG
40
ING Group
Netherlands
– -$2.16M -239,000 Closed
BCM
41
Bridgeway Capital Management
Texas
– -$2.11M -233,600 Closed
Wellington Management Group
42
Wellington Management Group
Massachusetts
– -$2.05M -227,229 Closed
DP
43
Diadema Partners
New Jersey
– -$1.81M -200,000 Closed
SFM
44
Sphera Funds Management
Israel
– -$1.63M -180,114 Closed
GCP
45
GSA Capital Partners
United Kingdom
– -$1.56M -172,363 Closed
SPS
46
Susquehanna Portfolio Strategies
Pennsylvania
– -$1.53M -168,884 Closed
Two Sigma Advisers
47
Two Sigma Advisers
New York
– -$1.41M -155,600 Closed
PFS
48
Prospera Financial Services
Texas
– -$1.37M -151,570 Closed
CFG
49
Citizens Financial Group
Rhode Island
– -$1.28M -142,193 Closed
Northern Trust
50
Northern Trust
Illinois
– -$1.22M -135,422 Closed
1
2
3 4 5

VTYX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2026, worth a combined $21K — down 100% from $472M a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of VTYX and 1 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $20.3K. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $58.6M sold.

  • 1 institutional investor held Ventyx Biosciences (VTYX) as of Q1 2026, down from 139 in Q4 2025.
  • Funds reported $21K of Ventyx Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 1 fund opened new Ventyx Biosciences positions in Q1 2026 and 138 closed out, a net change of -137 holders.
  • The largest Ventyx Biosciences buyer in Q1 2026 was IFP Advisors, an estimated $20.3K added.
  • The largest Ventyx Biosciences seller in Q1 2026 was Affinity Asset Advisors, an estimated $58.6M sold.

Based on aggregated 13F filings for Q1 2026.